THE BEST SIDE OF CDK2-IN-4

Antibodies will be the major class of therapeutics, thanks in large part for their capacity to interact with distinct ligand conformations in order to elicit unique biological responses. Even so, discovery of new molecules binding specific epitopes is time-consuming and hard, especially for cases necessitating a particular antibody-ligand orientati